Evropska unija - slovenščina - EMA (European Medicines Agency)

bausch health ireland limited - metilnaltreksonijev bromid - opioid-related disorders; constipation - obrobnih opioidni receptor antagonisti - zdravljenje z opioidi povzročeno zaprtje v napredno bolezni bolnikov, ki prejemajo paliativno oskrbo, ko odgovor na običajno laksativne zdravljenje ni bilo dovolj.

Evropska unija - slovenščina - EMA (European Medicines Agency)

viatris limited - tadalafil - hipertenzija, pljučnica - urološki - talmanco je indicirano pri odraslih za zdravljenje pljučne arterijske hipertenzije (pah) uvrščene, ki funkcionalno razreda ii in iii, izboljšati uresničevanje sposobnosti. učinkovitost so pokazali pri idiopatskem pah (ipah) in pri pah, povezani s kolagensko vaskularno boleznijo.

Evropska unija - slovenščina - EMA (European Medicines Agency)

regeneron uk limited - rilonacept - cryopyrin-associated periodic sindromov - imunosupresivi - rilonacept regeneron je indicirano za zdravljenje povezano s cryopyrin periodično sindromi (caps) s hudimi simptomi, vključno z družinsko hladno auto-vnetni sindrom (fcas) in muckle-wells sindrom (mws ki deluje), v odrasli in otroci, stari 12 let in starejši.

Evropska unija - slovenščina - EMA (European Medicines Agency)

3m health care limited - rivastigmin - alzheimerjeva bolezen - psychoanaleptics, , anticholinesterases - simptomatsko zdravljenje blage do zmerno hude alzheimerjeve demence.

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - sredstva za spreminjanje lipidov - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Evropska unija - slovenščina - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotična sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma (malta) limited - piperacilin; tazobaktam - prašek za raztopino za injiciranje/infundiranje - piperacilin 2 g / 1 viala  tazobaktam0,25 g / 1 viala; tazobaktam 0,25 g / 1 viala - piperacilin in zaviralec laktamaz beta

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma (malta) limited - piperacilin; tazobaktam - prašek za raztopino za injiciranje/infundiranje - piperacilin 2 g / 1 viala  tazobaktam0,25 g / 1 viala; tazobaktam 0,25 g / 1 viala - piperacilin in zaviralec laktamaz beta

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma (malta) limited - piperacilin; tazobaktam - prašek za raztopino za injiciranje/infundiranje - piperacilin 4 g / 1 viala  tazobaktam0,5 g / 1 viala; tazobaktam 0,5 g / 1 viala - piperacilin in zaviralec laktamaz beta

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

aurobindo pharma (malta) limited - piperacilin; tazobaktam - prašek za raztopino za injiciranje/infundiranje - piperacilin 4 g / 1 viala  tazobaktam0,5 g / 1 viala; tazobaktam 0,5 g / 1 viala - piperacilin in zaviralec laktamaz beta